Pirinixil is a hypolipidemic agent of low toxicity; it reduces total cholesterol in the spleen, kidney, and heart of rats; decreases estimated total body cholesterol by approximately 40%; significantly increases plasma cholesterol levels without affecting plasma triglycerides; markedly reduces liver cholesterol and triglycerides; decreases combined plasma and liver lipid levels by approximately 20%.